Not applicableStudy completedNCT02609529What this trial is testingSBI in Children With d-IBSWho this might be right forIrritable Bowel Syndrome Louisiana State University Health Sciences Center in New Orleans 20
Testing effectiveness (Phase 2)Study completedNCT01274000What this trial is testingEvaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female PatientsWho this might be right forIrritable Bowel Syndrome Astellas Pharma Inc 409
Post-approval studies (Phase 4)Study completedNCT03729271What this trial is testingHydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant DiarrheaWho this might be right forIrritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea University of Michigan 148
Testing effectiveness (Phase 2)Study completedNCT00189813What this trial is testingYM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)Who this might be right forIrritable Bowel Syndrome Astellas Pharma Inc 691
Large-scale testing (Phase 3)Ended earlyNCT01268618What this trial is testingTrenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional DyspepsiaWho this might be right forIBS-D and Functional Dyspepsia Sprim Advanced Life Sciences 120
Large-scale testing (Phase 3)Study completedNCT00067457What this trial is testingStudy In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyWho this might be right forIrritable ColonIrritable Bowel Syndrome (IBS) GlaxoSmithKline 700
Testing effectiveness (Phase 2)Study completedNCT00561535What this trial is testingEffect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS PatientsWho this might be right forIrritable Bowel Syndrome Assistance Publique - Hôpitaux de Paris 60
Not applicableUnknownNCT04095988What this trial is testingAllogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)Who this might be right forDiarrhea-predominant Irritable Bowel Syndrome University of Ulm 42
Large-scale testing (Phase 3)WithdrawnNCT02545413What this trial is testingStudy to Determine Efficacy of Probiotics in Irritable Bowel SyndromeWho this might be right forIrritable Bowel Syndrome Next Gen Pharma India Pvt. Ltd.
Large-scale testing (Phase 3)Study completedNCT01870895What this trial is testingAssess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)Who this might be right forDiarrhea-predominant Irritable Bowel Syndrome Astellas Pharma Inc 577
Post-approval studies (Phase 4)Study completedNCT00918411What this trial is testingA Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel SyndromeWho this might be right forIrritable Bowel Syndrome Astellas Pharma Inc 98
Not applicableNot Yet RecruitingNCT07425145What this trial is testingTranscutaneous Electrical Acustimulation for IBS-D: A Multicenter StudyWho this might be right forIBS, Diarrhea Predominant First People's Hospital of Foshan 200
Testing effectiveness (Phase 2)Study completedNCT02757105What this trial is testingRandomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)Who this might be right forIrritable Bowel Syndrome With Diarrhea RedHill Biopharma Limited 127
Large-scale testing (Phase 3)Study completedNCT01350570What this trial is testingAcupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled TrialWho this might be right forDiarrhea-predominant Irritable Bowel SyndromeFunctional Diarrhea Chengdu University of Traditional Chinese Medicine 449
Not applicableStudy completedNCT00616200What this trial is testingEffects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)Who this might be right forDiarrhea Predominant Irritable Bowel Syndrome University of North Carolina, Chapel Hill 17
Not applicableStudy completedNCT02419963What this trial is testingAnalyzing IBS to Identify Biomarkers and Microbiome SignaturesWho this might be right forDiarrhoea Predominant Irritable Bowel SyndromeIBS Mayo Clinic 26
Not applicableLooking for participantsNCT07000383What this trial is testingEvaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel SyndromeWho this might be right forDiarrhea-predominant Irritable Bowel SyndromeIrritable Bowel Syndrome of Diarrhea Type (IBS-D) University Medical Center Ho Chi Minh City (UMC) 90
Testing effectiveness (Phase 2)Study completedNCT04492787What this trial is testingEfficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)Who this might be right forIrritable Bowel Syndrome with Diarrhea Tasly Pharmaceutical Group Co., Ltd 240
Large-scale testing (Phase 3)Study completedNCT00067561What this trial is testingStudy Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyWho this might be right forIrritable ColonIrritable Bowel Syndrome (IBS) GlaxoSmithKline 702
Early research (Phase 1)Study completedNCT05816681What this trial is testingAssessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.Who this might be right forDiarrhea Daewoong Pharmaceutical Co. LTD. 60